We are live on ! Find out more
CMND icon

Clearmind Medicine

5 hedge funds and large institutions have $5.45M invested in Clearmind Medicine in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% less capital invested

Capital invested by funds: $5.49M → $5.45M (-$38.8K)

2.28% less ownership

Funds ownership: 13.99% → 11.71% (-2.3%)

17% less funds holding

Funds holding: 6 → 5 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

CMND Hedge Fund Activity: Q1 2025 in Review

5 of the 7,477 institutional investors tracked by Wall St. Rank reported a position in Clearmind Medicine (CMND) for Q1 2025, worth a combined $5.45M — down 0.71% from $5.49M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of CMND and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was AdvisorShares Investments, adding an estimated $70.9K. The largest seller was Virtu Financial, exiting entirely with an estimated $54K sold.

  • 5 institutional investors held Clearmind Medicine (CMND) as of Q1 2025, down from 6 in Q4 2024.
  • Funds reported $5.45M of Clearmind Medicine stock for Q1 2025, down 0.71% quarter-over-quarter.
  • 1 fund opened new Clearmind Medicine positions in Q1 2025 and 2 closed out, a net change of -1 holder.
  • The largest Clearmind Medicine buyer in Q1 2025 was AdvisorShares Investments, an estimated $70.9K added.
  • The largest Clearmind Medicine seller in Q1 2025 was Virtu Financial, an estimated $54K sold.

Based on aggregated 13F filings for Q1 2025.